Your browser doesn't support javascript.
loading
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trial.
Hernando-Calvo, Alberto; Malone, Eoghan; Day, Daphne; Prawira, Amy; Weinreb, Ilan; Yang, S Y Cindy; Wong, Horace; Rodriguez, Angela; Jennings, Sarah; Eliason, Anneli; Wang, Lisa; Spreafico, Anna; Siu, Lillian L; Hansen, Aaron R.
Afiliación
  • Hernando-Calvo A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Malone E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Day D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Prawira A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Weinreb I; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Yang SYC; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Wong H; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Rodriguez A; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Jennings S; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Eliason A; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Wang L; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Cancer Med ; 12(20): 20299-20310, 2023 10.
Article en En | MEDLINE | ID: mdl-37818869
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de las Glándulas Salivales / Carcinoma de Células Acinares Tipo de estudio: Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de las Glándulas Salivales / Carcinoma de Células Acinares Tipo de estudio: Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Canadá